Pulmonary hypertension in men with thyrotoxicosis

Respiration

Volumn 72, Issue 1, 2005, Pages 90-94

  Soroush Yari, Ardeshir ^a   Burstein, Samuel ^a   Soo Hoo, Guy W ^a   Santiago, Silverio M ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Dyspnea; Hyperthyroidism; Pulmonary hypertension

Indexed keywords

DIGOXIN; PROPRANOLOL; PROPYLTHIOURACIL; THIAMAZOLE;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CASE REPORT; DISEASE ASSOCIATION; HUMAN; HYPERPARATHYROIDISM; LUNG ARTERY PRESSURE; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SYSTOLIC BLOOD PRESSURE; THYROTOXICOSIS; TREATMENT OUTCOME;

ADULT; AGED; ANTIHYPERTENSIVE AGENTS; ANTITHYROID AGENTS; DISEASE PROGRESSION; DRUG THERAPY, COMBINATION; ECHOCARDIOGRAPHY; HUMANS; HYPERTENSION, PULMONARY; IODINE RADIOISOTOPES; MALE; MIDDLE AGED; PROPRANOLOL; PROPYLTHIOURACIL; PULMONARY WEDGE PRESSURE; THYROTOXICOSIS; THYROTROPIN; THYROXINE;

EID: 16344375305     PISSN: 00257931     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083408     Document Type: Article

References (32)

1. Ayres J, Rees TJ, Clark TJ, et al: Thyrotoxicosis and dyspnea. Clin Endocrinol 1982;16:65.
2. Stein M, Kimbel P, Johnson RL: Pulmonary function in hyperthyroidism. J Clin Invest 1961;40:348-361.
3. Zwillich CW, Matthay MA, Potts DE, et al: Thyrotoxicosis: Comparison of effects of thyroid ablation and beta-adrenergic ventilatory control. J Clin Endocrinol Metab 1978;46:491-500.
4. Skelton CL: The heart and hyperthyroidism. N Engl J Med 1982;307:1206-1208.
5. Mier A, Brophy C, Wass JAH, et al: Reversible respiratory muscle weakness in hyperthyroidism. Am Rev Respir Dis 1989;139:529-533.
6. Humbert M, Hilario N, Sitbon, et al: Risk factors for pulmonary hypertension. Clin Chest Med 2001;22:459-475.
7. Peacock AJ: Primary pulmonary hypertension. Thorax 1999;54:1107-1118.
8. Gaine S: Pulmonary hypertension. JAMA 2000;284:3160-3168.
9. Runo JR, Loyd JE: Primary pulmonary hypertension. Lancet 2003;361:1533-1544.
10. Jones A, Evans T: Pulmonary hypertension; in Albert R, Spiro S, Jett J (eds): Comprehensive Respiratory Medicine. London, Mosby, 1999, vol 10, pp 51.1-51.10.
11. Murray JF: Disorders of the pulmonary circulation: General principles and diagnostic approach; in Murray JF, Nadel JA, Mason RJ, Boushey HA (eds): Textbook of Respiratory Medicine, ed 3. Philadelphia, Saunders, 2000, pp 1485-1502.
12. Alcazar R, Rey M, de Sequera P, et al: The reversibility of pulmonary hypertension associated with autoimmune hyperthyroidism. Rev Esp Cardiol 1995;48:14204.
13. Agraou B, Tricot O, Strecker A, et al: Hyperthyroidism associated with pulmonary hypertension. Arch Mal Cœur 1996;89:765-768.
14. Thurnheer R, Jenni R, Russi EW, et al: Hyperthyroidism and pulmonary hypertension. J Intern Med 1997;242:185-188.
15. Nakchbandi IA, Wirth JA, Inzucchi SE: Pulmonary hypertension caused by Graves' thyrotoxicosis. Chest 1999;116:1483-1485.
16. Nduwayo L, Pop C, Heim J: Reversible pulmonary hypertension in Graves' disease. Presse Méd 2000;29:2216-2218.
17. Herrera GM, Fernandez Gonzalez MJF, Salgado Blanco J, et al: Hyperthyroidism, jaundice and pulmonary hypertension. An Med Interna (Madrid) 2001;18:262-264.
18. Polo Romero FJ, Fernandez Pelaez JM, Gato Diez A, Hernandez Lopez A: Pulmonary hypertension and hyperthyroidism in a pregnant woman. Med Clin (Barc) 2001;117:276-277.
19. Moraza J, Esteban C, Aburto M, et al: Reference figures of pulmonary artery pressures after effective treatment of Graves' disease. Arch Bronconeumol 2003;39:45-47.
20. Doughery MJ, Craige E: Apathetic hyperthyroidism presenting as tricuspid regurgitation. Chest 1973;63:767-772.
21. Okura H, Takatsu Y: High-output heart failure as a cause of pulmonary hypertension. Intern Med 1994;33:363-365.
22. Vazquez DI, Rui FR, Lozano EP, et al: Severe tricuspid regurgitation as the main manifestation of hyperthyroidism. Rev Esp Cardiol 1997;50:65-66.
23. Lazarus JH: Hyperthyroidism. Lancet 1997;349:339-343.
24. Klein I, Ojamaa K: Thyroid hormone and the cardiovascular system. N Engl J Med 2001;344:501-509.
25. Burggraaf J, Tulen JH, Lalezari S, et al: Sympathovagal imbalance in hyperthyroidism. Am J Physiol Endocrinol Metab 2001;281:E190-E195.
26. Rees Smith B, McLachlan SM, Furmaniak J: Autoantibodies to the thyrotropin receptor. Endocr Rev 1988;9:106-121.
27. Weetman AP: Graves' disease. N Engl J Med 2000;343:1236-1248.
28. O'Donovan D, McMahon C, Costigan C, et al: Reversible pulmonary hypertension in neonatal Graves disease. Ir Med J 1997;90:147-148.
29. Yanai-Landau H, Amital H, Bar-Dayan Y, et al: Autoimmune aspects of primary pulmonary hypertension. Pathobiology 1995;63:71-75.
30. Chu JW, Kao PN, Faul JL, Doyle RL: High prevalence of autoimmune thyroid disease in pulmonary arterial hypertension. Chest 2002;122:1668-1673.
31. Wilson R, McKillop JH, Chopra M, et al: The effect of antithyroid drugs on B and T cell activity in vitro. Clin Endocrinol 1988;28:389-397.
32. Marvisi M, Brianti M, Marani G, et al: Hyperthyroidism and pulmonary hypertension. Respir Med 2002;96:215-220.